Hyperglycemia modulates plasminogen activator inhibitor-1 expression and aortic diameter in experimental aortic aneurysm disease
- 21 June 2010
- journal article
- society of-university-surgeon
- Published by Elsevier BV in Surgery
- Vol. 148 (2), 429-435
- https://doi.org/10.1016/j.surg.2010.05.014
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Enhanced Abdominal Aortic Aneurysm Formation in Thrombin-Activatable Procarboxypeptidase B–Deficient MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Angiogenic sprouting from the aortic vascular wall is impaired in the BB rat model of autoimmune diabetesMicrovascular Research, 2008
- Reduced expansion rate of abdominal aortic aneurysms in patients with diabetes may be related to aberrant monocyte-matrix interactionsEuropean Heart Journal, 2008
- Overexpression of PAI-1 prevents the development of abdominal aortic aneurysm in miceGene Therapy, 2007
- Topology of the fibrinolytic system within the mural thrombus of human abdominal aortic aneurysmsThe Journal of Pathology, 2007
- Rho-kinase mediates hyperglycemia-induced plasminogen activator inhibitor-1 expression in vascular endothelial cells.Circulation, 2005
- The Influence of 4G/5G Polymorphism in the Plasminogen Activator Inhibitor-1 Gene Promoter on the Incidence, Growth and Operative Risk of Abdominal Aortic AneurysmEuropean Journal of Vascular and Endovascular Surgery, 2002
- Risk factors for postoperative death following elective surgical repair of abdominal aortic aneurysm: results from the UK Small Aneurysm TrialBritish Journal of Surgery, 2000
- Relative Contribution of Insulin and Its Precursors to Fibrinogen and PAI-1 in a Large Population With Different States of Glucose ToleranceArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Plasminogen activator and plasminogen activator inhibitor expression by normal and aneurysmal human aortic smooth muscle cells in cultureEuropean Journal of Vascular and Endovascular Surgery, 1995